GUILDFORD, England,
February 1, 2017 /PRNewswire/ --
- Dr
Hubert Bland appointed
as UK Medical Chair and Medical Head of
Diabetes and Cardiovascular
for UK & Ireland -
Sanofi today announces the appointment of Hugo Fry as General Manager for the UK and
General Manager Sanofi Pasteur for the UK & Ireland, and Dr Hubert
Bland as UK Medical Chair and Medical Head of Diabetes and
Cardiovascular for the UK & Ireland.
(Logo:
http://mma.prnewswire.com/media/463432/Sanofi_Logo.jpg )
(Photo:
http://mma.prnewswire.com/media/463431/Sanofi_Hugo_Fry.jpg )
(Photo:
http://mma.prnewswire.com/media/463430/Sanofi_Hubert_Bland.jpg
)
Commenting on his appointment, Hugo
Fry said: "I am honoured
to be appointed as General Manager
for the UK. I am proud and motivated
to lead our more than 1,800
UK colleagues, who continuously demonstrate their
commitment to serving the people whose lives we
touch. Our ambition in the UK is to
be a partner in improving the
nation's health. We are dedicated to
leveraging the unique diversity of our portfolio and
strength of our pipeline to empower people to live life to
the fullest."
Hubert Bland added:
"The UK healthcare system is under constant pressure
therefore the demand for new and effective
treatments, services and solutions
is ever-increasing. An effective medical function within
Sanofi is vital to ensure we are there for people in the
moments that matter. I am committed
to leading a team that
functions at the highest level of
quality standards and adds significant value to
healthcare professionals and other relevant
stakeholders on behalf of Sanofi in the UK."
Hugo has over 20 years of experience in the pharmaceutical
industry and has held various Global and regional management,
commercial and strategic roles. Prior to assuming this role, Hugo
was the Chief Marketing Officer for Sanofi Pasteur MSD (SPMSD),
leading the commercial effort for the European Vaccine Joint
Venture. He brings a wealth of experience in commercial leadership,
and delivering growth and driving performance in healthcare.
Hubert joins Sanofi from TMC Pharma, where he held the role of
Vice President of Medical since 2013. Prior to this, he held
medical leadership positions at Pfizer, Boehringer-Ingelheim, Linde
and the University of Surrey's
Clinical Research Centre. Hubert graduated from the University of
Cape Town Medical School in 1991, and thereafter spent nine years
training and practising in Internal Medicine, Anaesthetics,
Intensive Care and Exercise Medicine in the UK before joining the
pharmaceutical industry. He maintains his licence to practise
medicine and is currently an Educational Supervisor and Member of
the Faculty of Pharmaceutical Physicians.
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and
distributes therapeutic solutions focused on patients' needs.
Sanofi is organised into five global business units: Diabetes and
Cardiovascular, General Medicines and Emerging Markets, Sanofi
Genzyme, Sanofi Pasteur and Consumer Healthcare. Sanofi is listed
in Paris (EURONEXT: SAN) and in
New York (NYSE: SNY).